We have continued to improve year on year, and during
2010/11:
9729 patients were recruited to take part in research
£29m of external research funding was awarded to researchers working within the Trust
723 clinical research studies were underway
262 new studies were approved
81 external researchers applied to conduct studies within the Trust
5 studies at our Wellcome Trust Children's Clinical Research Facility were the first in the world to recruit participants
We have continued to significantly strengthen our research infrastructure during 2010/11:
Developing our researchers
Our Biomedical Research Centre created an Academy for Training and Education , to provide opportunities for researchers from all backgrounds to develop their careers. This will help young researchers mature into leading, independent investigator and will secure the future of research and innovation across our hospitals.
We continue to attract
high-profile researchers to Manchester, notably during 2010/11 with
the appointment of Professor Garth Cooper. Prof
Cooper leads our new CADET facility and is a world-leading expert
in drug discovery. He has published over 200 articles in
leading journals, as well as being named as inventor on more than
40 US and European patents.
Our nurses, midwives and allied health professionals (AHPs) have also had great success in receiving awards to enable further study and development. Seven Trust employees have secured prestigious NIHR research bursaries to study for Masters in Research. Nurses, midwives and AHPs have a research strategy that links with the overall Trust research strategy, and reinforces our goals of outstanding multi-professional research and innovation.
Working with commercial partners
Our work with industry partners has strengthened during 2010/11. ICON Development Solutions are now based on our hospital campus, and many research projects underway within our facilities are commercially sponsored.
The Biomedical Research Centre has joined forces with GlaxoSmithKline and The University of Manchester to create a new Manchester Centre for Nuclear Hormone Research in Disease . The centre is the first of its kind to see the NHS, academics and industry working together to find new treatments for inflammatory conditions such as asthma and rheumatoid arthritis. This work also includes the appointment of GSK's Professor Stuart Farrow as Chair in Experimental Therapeutics at the Biomedical Research Centre.
The next 12 months
"Over the coming year, we will build on the success of our NIHR Manchester Biomedical Research Centre . We aim to bring about further benefits to our patients as a result of continued investment in world-class researchers and facilities.
"We look forward to increasing our collaborations with commercial partners, particularly as we redevelop the former Manchester Royal Eye Hospital into an international centre for companies working in healthcare research. This will help us to speed up the pace of innovation in the NHS, and lead to improved care and treatment for our patients."
Professor Colin Sibley
